Lund University Cancer Centre – Clinical Trials and Diagnostics Meeting

We welcome you to the first meeting of a new Lund University Cancer Centre (LUCC) network, LUCC Clinical Trials and Diagnostics, devoted to sharing expertise and experiences in running clinical trials in cancer and connected translational biomarker studies: 

LUCC – Clinical Trials and Diagnostics Meeting

Day: 27 November 2025

Time: 13:00 – 16:00

Location: Room Bengt, Inspira Building, Medicon Village, Scheelevägen 4, Lund

Agenda:

• Welcome and vision for LUCC Clinical Trials & Diagnostics network
• Introductions of participants

Speakers

• Sara Alkner (SUS/LU) – Learnings from the ongoing phase 3 randomized non-inferiority T-REX clinical trial of external beam radiotherapy in early breast cancer
• Markus Heidenblad (LU) – Center for Translational Genomics (CTG) – Genomic and Biomarker Platforms Supporting Clinical Trials
• Peter Ellmark (Alligator Bioscience AB) – CD40 agonist with mFOLFIRINOX in pancreatic cancer: biomarkers associated with outcomes from OPTIMIZE-1
• Mats Jerkeman (SUS/LU) – CAR-T trial for lymphoma
• TBD 
• Discussion of future LUCC-CTaD activities

The invitation is open to experts with clinical experience in cancer across academia, healthcare, and industry.

Please register to help us plan fika and coffee/tea

Lao Saal, Associate Professor in Translational Oncogenomics at Lund University, Sweden &

Mats Jerkeman, Professor in Clinical Oncology at Lund University, Sweden, and Senior Consultant at Skane University Hospital, Lund, Sweden